Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America Dirk Schlimm and Al-Huda International

and Al-Huda International

Filled with color illustrations throughout

Time and again

motors and sensors

EAN: 9780071749206

Biologics in Inflammatory Bowel Disease, An issue of Gastroenterology Clinics of North America Dirk Schlimm and Al-Huda InternationalBy the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we come a long way in understanding the efficacy and safety of infliximab, we are beginning to understand how and when to use the drug. Furthermore, as of this writing, we have five other biologic agents